Cormorant Asset Management, LP
Related Filers (99)
- Chen Bihua (93)
- Cormorant Global Healthcare Master Fund, LP (88)
- Cormorant Private Healthcare Fund III LP (40)
- Cormorant Private Healthcare Fund II, LP (28)
- Cormorant Global Healthcare GP, LLC (15)
- PROTEOSTASIS THERAPEUTICS, INC. (13)
- Erasca, Inc. (10)
- CORMORANT PRIVATE HEALTHCARE FUND I, LP (9)
- Ambrx Biopharma Inc. (9)
- Turning Point Therapeutics, Inc. (8)
- CONSTELLATION PHARMACEUTICALS INC (7)
- Prometheus Biosciences, Inc. (7)
- Olema Pharmaceuticals, Inc. (7)
- Cabaletta Bio, Inc. (7)
- Corbus Pharmaceuticals Holdings, Inc. (6)
- Apellis Pharmaceuticals, Inc. (6)
- Avidity Biosciences, Inc. (6)
- Design Therapeutics, Inc. (6)
- Biomea Fusion, Inc. (6)
- OMEROS CORP (6)
- Aerovate Therapeutics, Inc. (6)
- Monte Rosa Therapeutics, Inc. (6)
- BioAtla, Inc. (6)
- Immuneering Corp (6)
- Clearside Biomedical, Inc. (5)
- Kezar Life Sciences, Inc. (5)
- Atea Pharmaceuticals, Inc. (5)
- Tarsus Pharmaceuticals, Inc. (5)
- Elevation Oncology, Inc. (5)
- EyePoint Pharmaceuticals, Inc. (5)
- Quotient Ltd (4)
- Axonics Modulation Technologies, Inc. (4)
- Kiniksa Pharmaceuticals, Ltd. (4)
- CONTRAFECT Corp (4)
- Dicerna Pharmaceuticals Inc (4)
- Mirati Therapeutics, Inc. (4)
- InflaRx N.V. (4)
- Principia Biopharma Inc. (4)
- Longboard Pharmaceuticals, Inc. (4)
- Revolution Medicines, Inc. (4)
- GreenLight Biosciences Holdings, PBC (4)
- Eledon Pharmaceuticals, Inc. (4)
- Cormorant Private Healthcare Fund IV LP (4)
- Aptose Biosciences Inc. (3)
- Gemphire Therapeutics Inc. (3)
- Cellectar Biosciences, Inc. (3)
- TiGenix NV (3)
- Zynerba Pharmaceuticals, Inc. (3)
- ANAPTYSBIO INC (3)
- AVROBIO, Inc. (3)
- Forma Therapeutics Holdings, Inc. (3)
- Viridian Therapeutics, Inc.\DE (3)
- AVEO PHARMACEUTICALS, INC. (3)
- Galecto, Inc. (3)
- Stoke Therapeutics, Inc. (3)
- ChemoCentryx, Inc. (3)
- OTONOMY, INC. (3)
- C4 Therapeutics, Inc. (3)
- Astria Therapeutics, Inc. (3)
- Minerva Neurosciences, Inc. (2)
- MyoKardia Inc (2)
- Recro Pharma, Inc. (2)
- SUNESIS PHARMACEUTICALS INC (2)
- GENVEC INC (2)
- Ignyta, Inc. (2)
- Intec Pharma Ltd. (2)
- Trillium Therapeutics Inc. (2)
- Immunovant, Inc. (2)
- X4 Pharmaceuticals, Inc (2)
- NextCure, Inc. (2)
- Akouos, Inc. (2)
- AGENUS INC (2)
- Arcturus Therapeutics Holdings Inc. (2)
- Rain Therapeutics Inc. (2)
- Verve Therapeutics, Inc. (2)
- Icosavax, Inc. (2)
- Tyra Biosciences, Inc. (2)
- Pyxis Oncology, Inc. (2)
- Ventyx Biosciences, Inc. (2)
- Vigil Neuroscience, Inc. (2)
- 89bio, Inc. (2)
- Tango Therapeutics, Inc. (2)
- VectivBio Holding AG (2)
- Altimmune, Inc. (2)
- Arcellx, Inc. (2)
- MoonLake Immunotherapeutics (2)
- MARINUS PHARMACEUTICALS, INC. (2)
- ALPINE IMMUNE SCIENCES, INC. (2)
- Ambrx Biopharma, Inc. (2)
- Korro Bio, Inc. (2)
- Sorrento Therapeutics, Inc. (1)
- ARDELYX, INC. (1)
- Vitae Pharmaceuticals, Inc (1)
- EIGER BIOPHARMACEUTICALS INC (1)
- ALX ONCOLOGY HOLDINGS INC (1)
- Harpoon Therapeutics, Inc. (1)
- VYNE Therapeutics Inc. (1)
- Praxis Precision Medicines, Inc. (1)
- Neurogene Inc. (1)
- Show More ...
Other (42)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Tuesday, 5/17/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/17/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/15/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (325)
SC 13G
Wednesday, 2/14/2024
Neurogene Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Korro Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
89bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Astria Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ambrx Biopharma, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Design Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
MARINUS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Longboard Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Elevation Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aerovate Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Eledon Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Praxis Precision Medicines, Inc.: Major Shareholders
4
Tuesday, 2/6/2024
Corbus Pharmaceuticals Holdings, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/30/2024
Erasca, Inc.: Major Shareholders
4
Tuesday, 1/30/2024
Corbus Pharmaceuticals Holdings, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/30/2024
Corbus Pharmaceuticals Holdings, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/11/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 12/14/2023
EyePoint Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 12/12/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/6/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/6/2023
EyePoint Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 11/16/2023
Korro Bio, Inc.: Major Shareholders
SC 13G
Monday, 11/13/2023
VYNE Therapeutics Inc.: Major Shareholders
SC 13G
Monday, 11/6/2023
Harpoon Therapeutics, Inc.: Major Shareholders
4
Wednesday, 10/25/2023
Ambrx Biopharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/23/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G
Friday, 10/13/2023
ALX ONCOLOGY HOLDINGS INC: Major Shareholders
SC 13G
Tuesday, 10/10/2023
MARINUS PHARMACEUTICALS, INC.: Major Shareholders
4
Tuesday, 10/10/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/19/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/24/2023
GreenLight Biosciences Holdings, PBC: Statement of changes in beneficial ownership of securities
4
Monday, 6/26/2023
Erasca, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/8/2023
GreenLight Biosciences Holdings, PBC: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 4/24/2023
Immuneering Corp: Major Shareholders
3
Monday, 4/24/2023
Immuneering Corp: Initial statement of beneficial ownership of securities
4
Thursday, 4/20/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/17/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2023
Ambrx Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/13/2023
Ambrx Biopharma Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 3/13/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Arcellx, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Prometheus Biosciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BioAtla, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
VectivBio Holding AG: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Astria Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
GreenLight Biosciences Holdings, PBC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Longboard Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Altimmune, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Design Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Tango Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Immuneering Corp: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Eledon Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Aerovate Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Elevation Oncology, Inc.: Major Shareholders
SC 13G
Thursday, 12/29/2022
89bio, Inc.: Major Shareholders
SC 13G
Tuesday, 12/27/2022
Avidity Biosciences, Inc.: Major Shareholders
SC 13D/A
Wednesday, 12/21/2022
Erasca, Inc.: Major Shareholders
4/A
Wednesday, 12/21/2022
Erasca, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
Erasca, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/31/2022
Cabaletta Bio, Inc.: Major Shareholders
SC 13G
Friday, 9/2/2022
Astria Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 8/29/2022
Arcellx, Inc.: Major Shareholders
SC 13G
Thursday, 7/7/2022
Altimmune, Inc.: Major Shareholders
4
Friday, 6/24/2022
Biomea Fusion, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 6/17/2022
VectivBio Holding AG: Major Shareholders
SC 13G
Tuesday, 6/7/2022
Prometheus Biosciences, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Eledon Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Revolution Medicines, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Tarsus Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Forma Therapeutics Holdings, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Aerovate Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
Turning Point Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
OTONOMY, INC.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Avidity Biosciences, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Atea Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Longboard Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
Tango Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Ambrx Biopharma Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Prometheus Biosciences, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Olema Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Galecto, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
BioAtla, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
OMEROS CORP: Major Shareholders